Applied Genetic Technologies Corp

Market cap: $

Exchange: NAS

Sector: Health Technology

Applied Genetic Technologies Corp. is a clinical stage biotechnology company, which engages in the development of gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. It has clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, and Barry J. Byrne on January 19, 1999 and is headquartered in Alachua, FL.

STOCK PRICE CHART

Key Statistics

Company Name

Applied Genetic Technologies Corp

Average Volume (10 days)

Average Volume (30 days)

Moving Average (50 days)

Moving Average (200 days)

Ex-Divided Date

n/a

Dividend Yield

P/E Ratio

Market Cap

Shares Outstanding

67,632,195

52-Week High Split Adjust Only

52-Week Low Split Adjust Only

Employee Count

Beta

Next Earnings Date

TTM Dividend Rate Per Share

Price Changes

Past 5 days

Past 30 days

Past 3 months

Past 6 months

Past year

Past 2 years

Past 5 years

Max % Change

PEER GROUP COMPARATIVE PERFORMANCE

Name	Ticker	Price/Sales (ttm)	Price/Book (ttm)	Forward P/E	PEG Ratio	EV/Revenue
Applied Genetic Technologies Corp	AGTC	n/a	n/a	-2.0	n/a	n/a
Peer Avg	N/A	34.12	3.14	-11.0	34.12	29.30
Intra-Cellular Therapies Inc	ITCI	n/a	n/a	-12.2	n/a	n/a
Bluebird bio Inc	BLUE	8.69	1.75	n/a	8.69	4.50
Curis Inc	CRIS	127.79	10.81	-32.0	127.79	112.71
Organovo Holdings Inc	ONVO	n/a	n/a	n/a	n/a	n/a